SCHEMBL13720547

SCHEMBL13720547

CC(C)(C)OC(=O)NC[C@]1(c2ccccc2)C[C@H]1CO

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.41
CPB2 Q96IY4 2/20 0.40
SYK P43405 1/20 0.40
NPFFR1 Q9GZQ6 1/20 0.39
NPFFR2 Q9Y5X5 1/20 0.39
ALDH1A1 P00352 1/20 0.38
ACACB O00763 4/20 0.38
OPRM1 P35372 1/20 0.38
OPRL1 P41146 1/20 0.38
KDM4A O75164 1/20 0.38
SIGMAR1 Q99720 1/20 0.37
CA12 O43570 1/20 0.37
CA1 P00915 1/20 0.37
CA7 P43166 1/20 0.37
CA14 Q9ULX7 1/20 0.37
ACACA Q13085 3/20 0.37
CTSS P25774 1/20 0.37
CTSK P43235 1/20 0.37
KMT2A Q03164 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13720351 0.88 IDO1 (0.42) IDO1CPB2NPFFR1NPFFR2SIGMAR1
SCHEMBL13720464 0.84 SYK (0.45) IDO1SYKNPFFR1NPFFR2ALDH1A1
SCHEMBL13720143 0.84 SYK (0.45) IDO1SYKNPFFR1NPFFR2ALDH1A1
SCHEMBL13720411 0.84 SYK (0.45) IDO1SYKNPFFR1NPFFR2ALDH1A1
SCHEMBL20005716 0.83 HCRTR2 (0.35) CPB2ALDH1A1KDM4AKMT2ADRD2
SCHEMBL20005977 0.83 HCRTR2 (0.35) CPB2ALDH1A1KDM4AKMT2ADRD2
SCHEMBL8208823 0.82 SLC6A3 (0.48) DRD2
SCHEMBL4874867 0.82 SLC6A3 (0.48) DRD2
SCHEMBL14255652 0.82 SLC6A3 (0.48) DRD2
SCHEMBL22917996 0.82 SLC6A3 (0.48) DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7569579-B2 for inhibition of HIV replication and treatment of acquired immune deficiency syndrome SMITHKLINE BEECHAM CORPORATION (US) 2009-08-04 US disclosed
US-7569579-B2 for inhibition of HIV replication and treatment of acquired immune deficiency syndrome SMITHKLINE BEECHAM CORPORATION (US) 2009-08-04 US disclosed
EP-1569934-B1 CYCLOPROPYL COMPOUNDS AS CCR5 ANTAGONISTS SMITHKLINE BEECHAM CORP (US) 2008-01-23 EP disclosed